Protein glycosylation affects nearly all molecular interactions at the cell surface and in the intercellular space. Many of the physiological variations which are part of homeostatic mechanisms influence glycosylation. However, a comprehensive overview of changes in glycosylation caused by aging and common lifestyle parameters is still lacking. After analyzing N-glycans in the plasma of 1914 individuals from the Croatian islands of Vis and Korčula, we performed a comprehensive analysis of the dependence of different glycosylation features (position of fucose, level of galactosylation, sialylation and branching) on aging, smoking, body fat and plasma lipid status. A number of statistically significant associations were observed. Glycosylation changes with aging were especially evident in females, mostly in association with the transition from pre-menopausal to post-menopausal age. Levels of corefucosylated, non-galactosylated, digalactosylated and disialylated biantennary glycans were shown to be mainly age dependent, but the level of branching and higher levels of galactosylation were found to correlate with lipid status. For the majority of glycans which we analyzed, all examined parameters explained up to 5% of the variance. The only notable exception were non-galactosylated glycans where 20% of the variance was explained mostly by age and blood pressure. In general, only a small fraction of the variability in glycan levels observed in a population was explained by age and other measured parameters, indicating that even in the absence of a genetic template, glycan levels are mostly determined by genetic background and/or specific pathophysiological processes.
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Introduction
Glycan chains attached to protein backbones are involved in nearly all molecular interactions at the cell surface and in the intercellular space. Changes in levels and composition of glycans were reported in numerous conditions (Packer et al. 2008) . However, before we could assign the observed changes to the well-characterized physiologic and/or pathophysiological processes, a more extensive knowledge of baseline characteristics and natural variations in glycosylation around homeostasis is needed. Gender, race, age, reproductive cycle, developmental stage, environmental influences, dietary habits and lifestyle habits such as smoking and alcohol consumption, which are all well-known effect modifiers and confounders in epidemiology, could contribute to the variability of the human glycome. Until very recently, quantitative analysis of glycans in a large number of individuals was nearly an impossible task. Mass spectrometry and capillary electrophoresis can provide high sample throughput, but mass spectrometry is still not reliable enough for quantitative analysis of even much simpler peptide mixtures (Bell et al. 2009 ), and capillary electrophoresis lacks resolution for detailed analysis of complex biological samples (Callewaert et al. 2001) .
High-performance liquid chromatography (HPLC) was a central tool for glycan analysis for decades, but it was only recently adapted for high-throughput glycan analysis (Royle et al. 2008) . Using this method, we performed a first large-scale study of glycans in normal human population. By comparing plasma N-glycan levels in 1008 individuals, we revealed the high variability that exists in a human population and identified several environmental factors that were associated with changes in some glycans ). More recently, we demonstrated that the plasma glycan profile of a single individual is remarkably stable over a short period of time, and also for as long as 1 year ), indicating that glycan profiles may be under substantial genetic control.
One of the most prominent features of any individual is its age, but effects of aging on human plasma glycans are still mostly unknown (Klein 2008) . Changes in glycan structures with age were mainly analyzed for glycans on immunoglobulin G. The largest study was performed on 403 individuals, and the main observation was that non-galactosylated glycoforms and glycoforms containing bisecting GlcNAc increase with age (Yamada et al. 1997) . Similar results were recently reported for the total human serum N-glycome in 100 individuals, but since the analysis was performed using capillary electrophoresis, inadequate resolution of the method limited this study to 10 most abundant glycan peaks (Vanhooren et al. 2007 ).
Smoking and dietary habits can influence life quality and life span. The World Health Organization claims that cardiovascular diseases are the world's largest killers, taking 17.1 million lives a year, and the most important behavioral risk factors of heart disease and stroke are unhealthy diet, physical inactivity and tobacco use. Behavioral risk factors are responsible for about 80% of coronary heart disease and cerebrovascular disease. Although there is no evidence that cardiovascular diseases and stress are directly associated with 960 Glycan feature Both genders; r, P Men; r, P Women; r, P Position of fucose Core fucosylated −0.22, P < 0.001 −0.08, P = 0.025 −0.31, P < 0.001 Antennary fucosylated −0.02, P = 0.305 0.13, P < 0.001 −0.13, P < 0.001 Level of sialylation Monosialylated −0.01, P = 0.785 0.13, P < 0.001 −0.09, P = 0.001 Disialylated −0.02, P = 0.508 −0.11, P = 0.002 0.04, P = 0.127 Trisialylated 0.03, P = 0.204 −0.07, P = 0.055 0.10, P = 0.001 Tetrasialylated 0.02, P = 0.463 0.05, P = 0.160 0.00, P = 0.930 Degree of branching Biantennary −0.04, P = 0.057 0.03, P = 0.486 −0.10, P = 0.001 Triantennary 0.04, P = 0.084 −0.04, P = 0.282 0.10, P < 0.001 Tetraantennary 0.05, P = 0.017 0.04, P = 0.305 0.08, P = 0.009 Level of sialylation of biantennary glycans Monosialylated biantennary −0.06, P = 0.011 0.05, P = 0.175 −0.12, P < 0.001 Disialylated biantennary 0.25, P < 0.001 0.11, P = 0.004 0.33, P < 0.001 Level of galactosylation Non-galactosylated 0.46, P < 0.001 0.36, P < 0.001 0.52, P < 0.001 Monogalactosylated 0.05, P = 0.038 0.09, P = 0.012 0.02, P = 0.520 Digalactosylated −0.29, P < 0.001 −0.18, P < 0.001 −0.36, P < 0.001 Trigalactosylated 0.06, P = 0.010 −0.04, P = 0.329 0.13, P < 0.001 Tetragalactosylated −0.11, P < 0.001 −0.09, P = 0.018 −0.12, P < 0.001 Biantennary non-galactosylated (A2) 0.30, P < 0.001 0.18, P < 0.001 0.37, P < 0.001
A Knežević et al. changes in N-glycosylation, there is some evidence that smoking and weight affects N-glycosylation (Thompson et al. 1991) and that polymorphisms in some genes involved in glycosylation are associated with body mass (Aulchenko et al. 2009 ).
Here, we present the first comprehensive study of association between N-glycans in human plasma and some major variations usually present in a population: individuals' age, body mass characteristics, lipid biochemical status and smoking habits.
Results
By performing high-throughput HPLC analysis of 2-AB-labeled glycans, we analyzed the main N-glycan features in the plasma of 1914 individuals (742 males and 1172 females) between 18 and 98 years of age. Glycans were released from plasma proteins with PNGase F, labeled with 2-AB and analyzed by hydrophilic interaction (HILIC) and weak anion exchange (WAX) HPLC as described in the Materials and methods section. By performing three HPLC runs for each sample, we separated the total human N-glycome into 33 chromatographic peaks (16 groups of glycans before desialylation; 13 groups of desialylated glycans; 4 groups of differentially charged glycans). Structures of major glycans in each individual peak were reported previously ) and are shown in Supplementary Table 1. Individual glycan features (percentage of biantennary non-galactosylated, biantennary monogalactosylated, core fucosylated, etc.) were calculated by adding and subtracting the main glycan structures as described in the Materials and methods section.
Glycan levels are sex and age dependent When we divided the population into gender groups, although the groups did not differ in their age composition, many of the Effects of aging and lifestyle on human plasma N-glycans investigated glycans showed significant differences between the male and female groups, indicating that the levels of some glycans are sex dependent. These differences were generally rather small but nevertheless were statistically significant for many glycan groups (Table I ).
In the next analysis step, all investigated glycans were correlated with age in order to identify glycan features for which the age composition of the population must always be taken in consideration in glycan studies. The results showed a number of significant correlations, usually larger in females than in males (Table II) . The most considerable correlations were observed for biantennary non-galactosylated glycan, corefucosylated glycans, disialylated forms of biantennary glycans, as well as non-galactosylated and digalactosylated glycans. Age-dependent increase in non-galactosylated glycans and corresponding decreases in digalactosylated glycans were observed in both males and females. The decreased level of digalactosylated glycans was accompanied with an increase in their sialylation. Interestingly, aging had opposing effects on fucosylation in males and females. Statistically significant decreases in both core and antennary fucose were observed in females, while an increase in antennary fucose was observed in males.
Since gender-specific differences in glycan changes could be the consequence of hormonal differences, the population was further divided into smaller age groups. Decade-based glycan analysis confirmed the existence of much stronger age-related patterns of glycan changes in females (Table III) . While for males we detected only three significant associations when all the decades were compared together and only non-galactosylated glycans showed statistically significant difference between pairs of subsequent decades (in later age, over 60), in females we found significant differences between pairs of decade groups for almost all main groups of glycan characteristics (Table III) . The vast majority of statistically significant differences were restricted to differences between the age groups of 40-49 and 50-59, indicating that the majority of age-related changes in glycans were a consequence of transition from pre-menopausal to post-menopausal stages.
Glycan levels are related to body and plasma lipid status Four body fat parameters (body mass index (BMI); waist to hip ratio (WH); bioelectrical resistive impedance (Z); and percentage of body fat (BF%)) were calculated as described in the Materials and methods section. Correlation coefficients between glycans and body fat parameters as well as systolic and diastolic blood pressures were calculated (Table  IV) . The pattern of statistically significant correlations (P ≤ 0.001) was not the same for all four body fat parameters, but increased body fat and blood pressure were generally associated with an increase in the non-galactosylated and a decrease in digalactosylated glycans as well as an increase in sialylation of biantennary structures.
Levels of total blood cholesterol, high-density lipoprotein (HDL)-cholesterol, low-density lipoprotein (LDL)-cholesterol and triglycerides can be an indication of unhealthy dietary habits and lifestyle since even in genetically induced dyslipidemias levels of blood lipids can be controlled by diet (Stacpoole et al. 1981 ). Significant correlations (P ≤ 0.001) in the direction of increased branching and sialylation and decreased core fucosylation were observed for all four lipid parameters. All three cholesterols were positively correlated with triantennary and tetraantennary structures, and this association was further confirmed by the same pattern of correlations between tri-and tetragalactosylated structures (Table IV) .
Hyperlipidemic persons can often have normal body weight but, due to genetic predispositions or dietary habits, have high 962 blood cholesterol and/or triglycerides. As the primary aim of this study was to investigate lifestyle, and not obesity, we compared the hyperlipidemic group with the normolipidemic group. Statistically significant differences were observed for many glycan features (Table V) .
Multivariate analysis
The pattern of correlations between body mass parameters and glycans was generally similar to the pattern of correlations between glycans and age, except for the monogalactosylated structures for which correlations were observed only for body fat parameters and not for aging. Since both body mass parameters and lipid status correlate with age, the possibility remained that some of the observed associations were a reflection of aging. To further investigate the significance of the impact of the analyzed personal characteristics on glycan levels, we performed a multiple regression analysis of age, body fat characteristics, lipid status and mean arterial pressure. Statistical significant associations (P values) are shown in Table VI and revealed which of the individual correlation coefficients shown in Table IV were the most statistically significant for changes in glycan levels. Levels of non-galactosylated glycans, digalactosylated glycans and core fucosylation were found to be influenced mostly by age, while the higher branching of glycans and their galactosylation levels were associated with plasma lipid status, with little or no age-dependent changes. Sialylation of biantennary structures was related to both age and body mass index.
Smoking is associated with increased branching and galactosylation of glycans Smoking is one of the most important risk factors for premature mortality globally. The standard parameter for smoking exposure measurement is the "Pack Year" (number of cigarettes per day multiplied by years of smoking/20 cigarettes), but this parameter does not allow for separate testing of longand short-term effects of smoking on glycans; thus, we used the number of cigarettes smoked per day and the number of years of smoking as two separate parameters. These parameters were also examined in people who stopped smoking at least 5 years ago. Correlation coefficients between different smoking parameters and glycan features are presented in Table VII . The strongest positive correlation of cigarettes smoked per day was observed with tetraantennary (P < 0.001) and tetragalactosylated (P < 0.001) glycans, while moderate correlations were also observed for core-fucosylated (P = 0.015) and biantennary glycans (P = 0.005). To investigate differences in glycan levels between smokers, ex-smokers and non-smokers, the population was divided into three groups. Since we showed that age is an important factor that affects glycan levels, we attempted to control for the influence of age by selecting three subpopulations which comprised the same number of individuals of matching age. Comparison of glycan levels between these groups identified statistically significant differences in the levels of antennary fucosylated and non-galactosylated glycans (Table VIII) .
Discussion
Using a recently developed method for high-throughput analysis of glycans, we performed the first comprehensive study of changes in total human plasma N-glycans with age and some factors that principally reflect lifestyle habits. Although aging is one of the most studied biological processes, little is known about the genetic and molecular mechanisms which influence this process in humans. Aging itself can be defined as a process which is genetically pre-determined, but this genetic influence must not be considered as programmed but rather as a physiological process that results from constant interaction between the genome and the environment (Ostojic et al. 2009 ). Considering the localization, sequence and function of protein glycosylation (Varki et al. 1999) , it is logical to expect that glycosylation of plasma proteins would change during life in humans and that these changes will comprise many glycan structures.
Our results show that changes in levels of glycan features with age are sex dependent and generally more evident in women than in men. It is interesting that some glycosylation features have reciprocal age dependence in these two sex 963 Table V . Glycan levels in subpopulations of hyperlipidemic (N = 448) and normolipidemic (N = 1538) subjects presented trough median and 25th and 75th percentiles. In both groups, there are 25% males and 75% females. Statistical significance (P) for differentiation of normolipidemic from hyperlipidemic group based on glycan levels is given.
Effects of aging and lifestyle on human plasma N-glycans groups. While in women antennary fucosylation was decreasing with age, in men it increased at the equivalent rate. The level of monosialylated glycans in men rose with age on the account of di-and trisialylated glycans, while in women sialylation was almost not changing during life. A particularly important observation was the increase in sialylation of digalactosylated glycans that was found to accompany a decrease in the total level of digalactosylated glycans in both aging and increased body fat and blood pressure. This indicated that normal glycoprotein production exceeds the maximal capacity of the sialylation machinery and that full sialylation can be achieved only when the production levels are decreased. This has important implications for the production of recombinant glycoproteins in human cell lines. Both fucose and sialic acid are sugars involved in many pathological processes (Sillanaukee et al. 1999; Becker and Lowe 2003; Yasukawa et al. 2005) , including inflammation, host immune response and tumor metastasis. Opposite changes in these glycan traits may be connected to immunological status, which changes with aging depending on sex, since sex hor- mones were shown to exhibit opposite inflammatory effects. In contrast to antennary fucose, a discernable negative correlation for core-fucosylated glycans was observed only in the female group, suggesting different roles for these two forms of fucosylation in the biology of aging. The most prominent difference in glycan levels in women are between age groups of 40-49 and 50-59, which implies the influence of hormonal status, since in this life period women usually enter the menopause and their hormonal status changes. The influence of hormones on glycan structures has been reported previously, and it is known that the level of estrogen correlates negatively with the sialyl Lewis X (trisialylated antennary fucosylated) glycan structure (BrinkmanVander Linden et al. 1996) . We did not find significant changes in total antennary fucosylation between these two critical age groups. Moreover, a modest decline with age was observed, suggesting that estrogen influence could be limited to sialyl Lewis X structure and not antennary fucosylation in general. It is also known that galactosylation of IgG increases during pregnancy, supporting the theory of hormonal influence on glycosylation changes. In men, statistically significant changes involve only a few glycan features and occur in later age groups. The only observed exception was galactosylation, for which the best linear associations with aging were detected for non-galactosylated glycan structures in both sex groups. These glycan structures are typical of IgG glycans and thus mainly reflect increased agalactosylation of IgG with aging. The increase in non-galactosylated structures was accompanied by a decrease in digalactosylated structures, while the level of monogalactosylated structures stayed the same, confirming the initial observation of glycan changes on IgG from over 20 years ago .
Although it is known that the process of "hormonal" aging in men exists, only a limited number of men experience the problems of this gradual loss of testosterone. However, menopause, a complete cessation of reproductive ability caused by the shutting down of the female reproductive system, occurs at once and affects the whole female population. It can be objected that the evident changes in glycosylation in women are a consequence of hormonal changes rather than the aging process itself and that changes in men better reflect the real glycan behavior caused by genetically pre-determined aspects of aging. However, women usually live longer than men, and maybe the linkage between hormonal status and aging should not be considered separately. Improvements in healthcare have also extended the human lifespan, and, although the process of aging is partially under genetic control it is also further influenced by the environment, and therefore the biological age of the individual does not necessarily correspond to chronological age (Wahlin et al. 2006) .
Estimation of body fat composition can be performed in several ways, and each method has its limitations (Lukaski et al. 1985; Deurenberg et al. 1991; Turconi et al. 2006; Henneberg and Ulijaszek 2010) . To avoid errors of individual estimations, we calculated all four scores to achieve the most reliable results. When we correlated these body fat parameters with the main structural features of glycans, levels of non-galactosylated and disialylated biantennary glycans were found to positively correlate with all four body fat parameters, but since these glycans were also strongly correlated with age after including all these characteristics in a multivariate analysis, the association of body fat parameters with these glycans diminished.
Human body fat levels are often connected with lipid status; therefore, we also looked for associations between glycans and cholesterol and lipoproteins. All lipoproteins transport cholesterol, and for many of them N-glycosylation is essential for function (Vukmirica et al. 2002; Vinals et al. 2003; Qu et al. 2006; Skropeta et al. 2007 ), but there are few data describing structural features of these N-linked glycans (Harazono et al. 2005) . Correlation of glycan features with these biochemical parameters revealed that tetragalactosylated structures posi- Table VIII . Levels of N-glycan subclasses by subpopulation of smokers (N = 175), non-smokers (N = 175) and ex-smokers (N = 175) presented trough median and 25th and 75th percentiles. In both groups, males are present as 47.4% and females as 52.6% Statistical significance (P) for differentiation of all three or separate pairs of groups based on glycan levels are given.
Effects of aging and lifestyle on human plasma N-glycans tively correlate with all of them, except triglycerides, for which correlation was in the opposite direction. It is unlikely that correlations between LDL and HDL and these glycans are the consequence of changes in the glycosylation of lipoproteins since most glycans on apoproteins are mono-or disialylated biantennary structures. Apo B100, which is part of LDL, is highly glycosylated, and its disialylated structures were shown to be decreased in hypercholesterolemia in rabbits (Millar 2001) . It is known that obesity results in low-grade chronic inflammation (Dupuis et al. 2010) , and there is evidence that C-reactive protein is elevated with weight gain (Saito et al. 2003) , and increased tri-and tetrasialylated structures are usually connected to inflammation (Gornik and Lauc 2008) . Also, although in the absence of acute or chronic inflammation, HDL acts as an anti-inflammatory agent, with the onset of a systemic inflammatory state such as atherosclerosis, HDL becomes pro-inflammatory, enhancing the inflammatory response (Parekh, Roitt, Isenberg, Dwek, Ansell, et al. 1988; Van Lenten et al. 1995) .
Smoking is an important behavioral risk factor for premature mortality that usually reflects lifestyle and attitudes toward personal health. Our results indicated that the number of cigarettes smoked per day is associated with increased levels of tetraantennary (P < 0.001) and tetragalactosylated (P < 0.001) structures and decreased levels of biantennary structures (P = 0.005) (Table VII) . These changes reflect increased N-glycan branching in smokers and might be associated with smoking-related inflammation since these changes are associated with inflammatory processes (Gornik and Lauc 2008) . This could also partly be the consequence of a decrease in IgG concentration, since higher consumption of cigarettes was reported to result in decreased IgG levels (McMillan et al. 1997) . Core fucosylation was also decreased in smokers (P = 0.015) (Table VII) , confirming the observation of decreased FUT8 activity in mice exposed to cigarette smoke in laboratory conditions (Taniguchi 2009 ). These novel observations represent preliminary findings which merit further study and replication in other populations. They provide some initial data on associations between important behavioral health risks and changes in levels of N-glycans which may yield new insights into mechanisms through which these risks may be mediated.
Conclusions
For the majority of glycans which we analyzed, all parameters together explained only up to 5% of the variance. The only notable exceptions were non-galactosylated glycans where 20% of the variance was explained. Since for the majority of glycans only a small fraction of variability observed in a population was explained by age and lifestyle parameters, it appears that even in the absence of a genetic template, glycan levels are mostly determined by genetic background and/or specific pathophysiological processes. Nevertheless, changes in glycan levels associated with age and environmental influences should be taken into consideration when glycan changes in different pathological conditions are being studied. Age is a particularly significant factor that relates to the glycosylation profiles of females, especially around menopausal age, which is the life period during which many pathological conditions in women originate. Glycosylation changes are a sensitive indicator of changes in the external or internal environment of the cell. Our increasing understanding of the inter-relatedness of the many systems that underpin both glycosylation and disease processes will provide tools with which we probe the relationships between them.
Materials and methods

Plasma samples
Blood samples were collected from unselected examinees from two Croatian Adriatic islands, Vis and Korcula as part of a larger genetic epidemiology program (Rudan et al. 1999 . The project aims were initially to describe the variability and genetic epidemiology of isolated island communities (Carothers et al. 2006; Polasek et al. 2006; Campbell et al. 2007; Vitart et al. 2008) , while in the later stages the focus has changed towards gene mapping efforts, some of which included notable successes (Vitart et al. 2008; Johansson et al. 2009; Dupuis et al. 2010) . All these successes support the suggestion that isolated communities present highly interesting research resources in human genetics (Vitart et al. 2006) . Participants were recruited on the basis of the official voting registers and contacts with the local stakeholders and religious communities in both islands. Sampling on the Vis Island took place in 2003 and 2004, while in Korcula Island it took place in 2007. All examinees were given detailed study information prior to the enrolment, and they had to sign the informed consent to enter the study. The study was approved by the appropriate ethical committees in both Croatia and Scotland. A total of 1991 individuals were recruited; 77 of them lacked data for some of the analyzed parameters and were excluded from the study, which was performed on 1914 individuals.
Over 250 different phenotypic traits of each subject were measured, supplemented by the blood samples. Blood was taken in epruvetes containing anticoagulant. Each blood sample was immediately processed; plasmas were separated and stored at −70°C.
Glycan analysis
Glycan release and labeling was performed as reported previously ). Plasma proteins were immobilized in a block of sodium dodecyl sulfate-polyacrylamide gel, and N-glycans were released by digestion with recombinant N-glycosidase F. This was done in a 96-well microtiter plate to achieve the best throughput of sample preparation. After extraction, glycans were fluorescently labeled with 2-aminobenzamide.
Hydrophilic interaction high-performance liquid chromatography Released glycans were subjected to hydrophilic interaction high-performance liquid chromatography (HILIC) on a 250 × 4.6 mm i.d. 5 μm particle packed TSKgel Amide 80 column (Tosoh Bioscience, Stuttgart, Germany) at 30°C with 50 mM formic acid adjusted to pH 4.4 with ammonia solution as solvent A and acetonitrile as solvent B. Sixty-minute runs were performed with fluorescence detector set with excitation and emission wavelengths of 330 and 420 nm, respectively. The system was calibrated using an external standard of hydrolyzed and 2-AB-labeled glucose oligomers from which the retention times for the individual glycans were converted to glucose units (GU).
The chromatograms obtained were all separated in the same manner to 16 chromatographic areas and 13 for desialylated glycans, considering the peak resolutions and similarity of glycan structures present as described before. The amounts of glycans present in each area were expressed as percent of total integrated chromatogram (amount of total glycan structures/ total serum N-glycome).
Weak anion exchange-HPLC Glycans were separated according to the number of sialic acids by weak anion exchange HPLC. The analysis was performed using a Prozyme GlycoSep C 75 mm × 7.5 mm column (Prozyme, Leandro, CA, USA) at 30°C with 20% (v/v) acetonitrile in water as solvent A and 0.1 M acetic acid adjusted to pH 7.0 with ammonia solution in 20% (v/v) acetonitrile as solvent B. Compounds were retained on the column according to their charge density, the higher charged compounds being retained the longest. A fetuin N-glycan standard was used for calibration.
Sialidase digestion
Aliquots of the 2-AB-labeled glycan pool were dried down in 96-well polymerase chain reaction plates. To these, the following were added: 1 μl of 500 mM sodium acetate incubation buffer (pH 5.5), 1 μl (0.005 units) of ABS, Arthrobacter ureafaciens sialidase (releases α2-3,6,8 sialic acid, Prozyme) and H 2 O to make up to 10 μl. This was incubated overnight (16-18 h) at 37°C and then passed through AcroPrep™ 96 Filter Plates, 350 µL well, 10K (Pall Corporation, Port Washington, NY, USA) before applying to the HPLC.
Glycan structural features
Levels of glycans sharing the same structural features were approximated by adding the structures having the same characteristic, from either HILIC, WAX or after sialidase treatment-integrated glycan profiles (individual glycan structures present in each glycan group that were reported previously are shown in Supplementary Table 1) . Glycans were quantified from WAX profiles according the level of sialylation (monosialylated, disialylated, trisialylated, tetrasialylated). Glycan features were defined as: core-fucosylated glycans (FUC-C) = DG6/(DG5 + DG6) * 100; antennary fucosylated glycans (FUC-A) = DG7/(DG5 + DG7) * 100; biantennary glycans (BA) = DG1 + DG2 + DG3 + DG4 + DG5 + DG6 + DG7; monosialylated biantennary glycans (BAMS) = (G7 + G8)/(DG5 + DG6 + DG7) * 100; disialylated biantennary glycans BADS = (G9 + G10 + G11)/(DG5 + DG6 + DG7) * 100; triantennary glycans (TRIA) = DG8 + DG9 + DG10; tetraantennary glycans (TA) = DG11 + DG12 + DG13; non-galactosylated glycans (G0) = DG1 + DG2; monogalactosylated glycans (G1) = DG3+DG4; digalactosylated glycans (G2) = DG5 + DG6 + DG7; trigalactosylated glycans (G3) = GP12 + GP13 + GP14; tetragalactosylated glycans (G4) = GP15 + GP16; biantennary non-galactosylated glycan (A2) = (GP1 + DG1)/2.
Observed parameters of dietary habits and smoking Estimation of body fat composition can be done in several ways, but they do not uniformly represent dietary habits. In this study, we used four anthropometric body fat estimation parameters: BMI, WH, bioelectrical resistive impedance (Z) and percentage of body fat calculated by Durnin-Womersley equation from four skinfold measurements (BF%). All subjects were measured for height, weight, hip circumference, waist circumference and skinfold thickness using calipers at four sites: biceps, triceps, subscapular and suprailiac. Bioelectrical resistive impedance was measured through resistance (R) and reactivity (Xc) just for Vis samples using STA-BIA analyser (Akern, Italy).
From these measured values, desirable parameters were calculated as follows: and c and m are age/sex-related constants (Durnin and Womersley 1974) .
We recorded systolic and diastolic blood pressure as average value of two independent measurements.
Biochemical parameters (lipoproteins, total blood cholesterol and triglycerides) can be more precise in estimating dietary habits than anthropometric measurements.
Total blood cholesterol was measured by photometry with cholesterol oxidase, triglycerides by UV photometry with glycerolphosphate-oxidase, HDL-cholesterol by homogene enzyme method with modified polyethylene glycol and acyclohexane-sulfate, and LDL-cholesterol was calculated according to Friedewald if the triglycerides were lower than 4.6 mmol/L (lab referent range).
Familial combined hyperlipidemia is the most common genetic dyslipidemia and a major risk factor for early coronary heart disease but dyslipidemia with same physiological effect (high cholesterol and triglycerides) can be also the result of bad dietary habits. We defined a subgroup of hyperlipidemic subjects as: total cholesterol >5.2 mmol/L and triglycerides >1.69 mmol/L.
Effects of smoking were based on average day consumption of cigarettes (DC) and number of smoking years (SY) for smokers and average day consumption of cigarettes (ExDC), number of smoking years (ExSY) and number of years since ex-smoker stopped smoking (ExStop) for exsmokers. A smoker was defined as a subject who smoked for at least 5 years, ex-smokers were defined as subjects who smoked in the past for at least 5 years and stopped smoking at least 5 years ago. Non-smokers were subjects who never smoked. To avoid sex and age corrections, we created a random subpopulation of 175 smokers, 175 nonsmokers and 175 ex-smokers matching by average age and percentage of males and females (in each group there were 47.4% males and 52.6% females).
Statistical analysis
The descriptive part of the statistical analysis was aimed at showing the basic characteristics of the population. The population was then tested for normality using SmirnovKolmogorov test, and nonparametric statistical tests were further used. Mann-Whitney test was used to analyze differences in levels of glycans between groups (males/females, normolipidemic/hyperlipidemic and smokers/ex-smokers/nonsmokers), while the Spearman's rank correlation was calculated for association of glycans' structures and age as well as all observed parameters of smoking and dietary habits. The multiple linear regression was used to analyze the association of selected predictor variables and each glycan feature.
Significance level was set at P ≤ 0.001.
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